Arch Dis Child Fetal Neonatal Ed 2001;85:F177-F181
( November )
Costs of different strategies for neonatal hearing screening: a
modelling approach
H C Boshuizena, G J van der Lemb, M A Kauffman-de Boerb, G A van Zantenc, A M Oudesluys-Murphyd, P H Verkerke
a TNO Prevention and
Health, Division of Public Health, Leiden, The Netherlands, b Dutch foundation of the Deaf and Hard
of Hearing Child, c Department of Audiology, Academic Hospital
Rotterdam/Sophia Children Hospital/Erasmus University Rotterdam,
Rotterdam, The Netherlands, d Department
of Paediatrics, Medical Center Rijnmond-Zuid, Location Zuider,
Rotterdam, e TNO
Prevention and Health, Division of Child Health and Health Care, Leiden
Correspondence to: Dr Boshuizen,
National Institute of Public Health and the Environment,
Computerisation and Methodological Consultancy Unit, PO Box 1, NL-3720
BA Bilthoven, The Netherlands
Hendriek.Boshuizen{at}RIVM.NL
Accepted 6 July 2001
OBJECTIVE
To compare
the cost effectiveness of various strategies for neonatal hearing
screening by estimating the cost per hearing impaired child detected.
DESIGN
Cost analyses
with a simulation model, including a multivariate sensitivity analysis.
Comparisons of the cost per child detected were made for: screening
method (automated auditory brainstem response or otoacoustic
emissions); number of stages in the screening process (two or three);
target disorder (bilateral hearing loss or both unilateral and
bilateral loss); location (at home or at a child health clinic).
SETTING
The
Netherlands
TARGET POPULATION
All
newborn infants not admitted to neonatal intensive care units.
MAIN OUTCOME
MEASURE
Costs per child detected with a hearing
loss of 40 dB or more in the better ear.
RESULTS
Costs of a
three stage screening process in child health clinics are
39.0 (95%
confidence interval 20.0 to 57.0) per child detected with automated
auditory brainstem response compared with
25.0 (14.4 to 35.6) per
child detected with otoacoustic emissions. A three stage screening
process not only reduces the referral rates, but is also likely to cost
less than a two stage process because of the lower cost of diagnostic
facilities. The extra cost (over and above a screening programme
detecting bilateral losses) of detecting one child with unilateral
hearing loss is
1500-4000. With the currently available
information, no preference can be expressed for a screening location.
CONCLUSIONS
Three
stage screening with otoacoustic emissions is recommended. Whether
screening at home is more cost effective than screening at a child
health clinic needs further study.
Keywords:
costs;
hearing;
screening;
otoacoustic emissions;
automated auditory brainstem response
© 2001 by Archives of Disease in Childhood